Marketing-authorisation holder · Canada
The Tetra Corporation
2 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
2 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| FORMULA 31 % / w/w · Solution | Tolnaftate | Canada | Marketed | 2014 |
| FUNGIFOAM ANTIFUNGAL1 % / w/w · Cream | Tolnaftate | Canada | Cancelled | 2019 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 2 | 1 | 1 | CompaniesAll medicines |
Therapeutic areas
The ATC groups most of its medicines belong to, largest first.
- Antifungals for dermatological useDermatologicals · ATC D01A
Top substances
The active substances in most of its medicines.